The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
Photodynamic therapy market to reach $2.04 billion by 2030 at 5.9% CAGR, driven by rising prevalence of skin cancer.
Read More
Phosphoramidite market to reach $1.5 billion by 2030 at 6.9% CAGR, driven by expansion of the biopharmaceutical sector.
Read More
Phosphoinositide 3-kinase (pi3k) inhibitors market to reach $2.88 billion by 2030 at 13.1% CAGR, driven by increasing prevalence of cancer and autoimmune diseases.
Read More
Phosphodiesterase 5 inhibitor market to reach $6.55 billion by 2030 at 6.9% CAGR, driven by increasing prevalence of erectile dysfunction and growth in research and clinical trials.
Read More
Phosphatidylethanolamine market to reach $0.85 billion by 2030 at 7.1% CAGR, driven by increasing demand for natural health supplements.
Read More
Phosphatidylcholine market to reach $2.02 billion by 2030 at 6.4% CAGR, driven by rising consumer demand for dietary supplements.
Read More
Phenylephrine drugs market to reach $44.82 billion by 2030 at 9.8% CAGR, driven by rising incidence of respiratory diseases.
Read More
The global phenobarbital market to reach $1.96 billion by 2030 at 5.0% CAGR, driven by increasing prevalence of epilepsy.
Read More
The global pharmerging market to reach $3674.16 billion by 2030 at 10.2% CAGR, driven by increasing healthcare expenditure.
Read More
Pharmacy inventory management software solutions and cabinets market to reach $10.05 billion by 2030 at 9.3% CAGR, driven by rising number of long-term care pharmacies.
Read More